Two Sigma Advisers
CELL

Two Sigma Advisers’s PhenomeX Inc. Common Stock CELL Stock Holding History

Two Sigma Advisers’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-128,568
Closed -$128K – 2707
2023
Q3 		$128K Sell
128,568
-278,885
-68% -$214K ﹤0.01% 2172
2023
Q2 		$200K Sell
407,453
-50,300
-11% -$41.1K ﹤0.01% 2102
2023
Q1 		$531K Sell
457,753
-233,047
-34% -$426K ﹤0.01% 1922
2022
Q4 		$1.85M Sell
690,800
-79,800
-10% -$210K 0.01% 1283
2022
Q3 		$2.2M Sell
770,600
-91,200
-11% -$388K 0.01% 1125
2022
Q2 		$4.28M Sell
861,800
-237,700
-22% -$1.25M 0.01% 848
2022
Q1 		$7.82M Sell
1,099,500
-4,100
-0.4% -$33.9K 0.02% 616
2021
Q4 		$20.1M Sell
1,103,600
-73,600
-6% -$1.59M 0.05% 308
2021
Q3 		$23M Buy
1,177,200
+1,006,200
+588% +$38.3M 0.06% 283
2021
Q2 		$7.66M Buy
171,000
+36,500
+27% +$1.69M 0.02% 667
2021
Q1 		$6.76M Buy
+134,500
New +$9.17M 0.02% 732

Two Sigma Advisers's CELL Position: Q4 2023 in Review

Two Sigma Advisers sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2023, closing a stake of 128,568 shares — an estimated $128K sold.

Two Sigma Advisers first reported a position in CELL in Q1 2021 and held it in 11 quarters. The position peaked at $23M in Q3 2021. 0 funds tracked by Wall St. Rank hold CELL as of Q4 2023.

  • Two Sigma Advisers reported no remaining PhenomeX Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Two Sigma Advisers sold 128,568 PhenomeX Inc. Common Stock shares in Q4 2023, an estimated $128K.
  • Two Sigma Advisers first reported a position in PhenomeX Inc. Common Stock in Q1 2021 and held it in 11 quarters.
  • Two Sigma Advisers's PhenomeX Inc. Common Stock position peaked at $23M in Q3 2021.
  • 0 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2023.

Based on Two Sigma Advisers's 13F filing for Q4 2023, filed 14 Feb 2024.